Short-Course Versus Long-Course Systemic Antibiotic Treatment for Uncomplicated Intravascular Catheter-Related Bloodstream Infections due to Gram-Negative Bacteria, Enterococci or Coagulase-Negative Staphylococci: A Systematic Review.
CRBSI
Catheter-related bloodstream infection
Coagulase-negative staphylococci
Enterococcal
Enterococcus
Gram-negative
Intravascular catheter infection
Journal
Infectious diseases and therapy
ISSN: 2193-8229
Titre abrégé: Infect Dis Ther
Pays: New Zealand
ID NLM: 101634499
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
29
03
2021
accepted:
22
05
2021
pubmed:
26
6
2021
medline:
26
6
2021
entrez:
25
6
2021
Statut:
ppublish
Résumé
The optimal duration of systemic antimicrobial treatment for catheter-related bloodstream infections (CRBSI) is unknown. In this systematic review, we aimed to assess the efficacy of short-course treatment for CRBSI due to Gram-negative bacteria, coagulase-negative staphylococci and enterococci. We systematically searched the electronic bibliographic databases MEDLINE, EMBASE and Cochrane Library for studies published before February 2021. All studies that investigated the duration of adequate systemic antibiotic treatment in adult patients with uncomplicated intravascular catheter infections due to Gram-negative bacteria, coagulase-negative staphylococci or enterococci were eligible for inclusion. Studies including concomitant treatment with antibiotic lock therapy were excluded. The primary outcomes were clinical failure/cure, mortality and microbiologic-confirmed relapse. Seven retrospective cohort studies and one case-cohort study met the inclusion criteria. No randomized controlled studies met inclusion criteria. The quality of the included studies was low (n = 7) to moderate (n = 1). No significant differences were observed regarding mortality and microbiological relapse between short-course and long-course systemic antibiotic treatment in patients with CRBSI due to coagulase-negative staphylococci or Gram-negative bacteria. No association was found between mortality and treatment duration in the two studies assessing enterococcal CRBSI. The limited data available suggests that shorter systemic antibiotic treatment duration may be sufficient for uncomplicated CRBSI. Further well-designed prospective studies are needed to confirm these findings. CRD42021224946 (PROSPERO).
Identifiants
pubmed: 34169480
doi: 10.1007/s40121-021-00464-0
pii: 10.1007/s40121-021-00464-0
pmc: PMC8322176
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1591-1605Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH)
ID : P4P4PM_194449
Informations de copyright
© 2021. The Author(s).
Références
Centers for Disease Control and Prevention. Central line-associated bloodstream infections: A.R. & Patient Safety Portal. 2019. https://arpsp.cdc.gov/profile/infections/CLABSI . Accessed 11 Jan 2021.
European Centre for Disease Prevention and Control. Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2017. ECDC; 2019 Oct. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-HAI.pdf .
Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136:229.
doi: 10.1001/archsurg.136.2.229
Olaechea PM, Palomar M, Álvarez-Lerma F, et al. Morbidity and mortality associated with primary and catheter-related bloodstream infections in critically ill patients. Rev Esp Quimioter. 2013;26:21–9.
pubmed: 23546458
Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection. 2015;43:29–36.
doi: 10.1007/s15010-014-0689-y
Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173:2039–46.
doi: 10.1001/jamainternmed.2013.9763
Novosad SA, Fike L, Dudeck MA, et al. Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011–2017. Infect Control Hosp Epidemiol. 2020;41:313–9.
doi: 10.1017/ice.2019.303
The Task Force for Combating Antibiotic-Resistant Bacteria. National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020–2025. 2020. https://aspe.hhs.gov/pdf-report/carb-plan-2020-2025 . Accessed 7 Jan 2021.
von Dach E, Albrich WC, Brunel A-S, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated Gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323:2160.
doi: 10.1001/jama.2020.6348
Yahav D, Franceschini E, Koppel F, et al. Seven versus 14 days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis. 2019;69:1091–8.
doi: 10.1093/cid/ciy1054
Tansarli GS, Andreatos N, Pliakos EE, Mylonakis E. A systematic review and meta-analysis of antibiotic treatment duration for bacteremia due to Enterobacteriaceae. Antimicrob Agents Chemother. 2019;63:e02495-e2518.
pubmed: 30803971
pmcid: 6496097
Li X, Liu C, Mao Z, Li Q, Qi S, Zhou F. Short-course versus long-course antibiotic treatment in patients with uncomplicated gram-negative bacteremia: a systematic review and meta-analysis. J Clin Pharm Ther. 2021;46:173–80.
doi: 10.1111/jcpt.13277
Böll B, Schalk E, Buchheidt D, et al. Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2021;100:239–59.
doi: 10.1007/s00277-020-04286-x
Timsit J-F, Baleine J, Bernard L, et al. Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit. Ann Intensive Care. 2020;10:118.
doi: 10.1186/s13613-020-00713-4
Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.
doi: 10.1086/599376
Chaves F, Garnacho-Montero J, Del Pozo JL, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intens. 2018;42:5–36.
doi: 10.1016/j.medin.2017.09.012
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
doi: 10.1371/journal.pmed.1000097
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.
doi: 10.1186/s13643-016-0384-4
Rupp ME, Karnatak R. Intravascular catheter-related bloodstream infections. Infect Dis Clin N Am. 2018;32:765–87.
doi: 10.1016/j.idc.2018.06.002
Buetti N, Timsit J-F. Management and prevention of central venous catheter-related infections in the ICU. Semin Respir Crit Care Med. 2019;40:508–23.
doi: 10.1055/s-0039-1693705
Wells G, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. 2000. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 19 Jan 2021.
Ruiz-Ruigómez M, Fernández-Ruiz M, San-Juan R, et al. Impact of duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli. J Antimicrob Chemother. 2020;75:3049–55.
doi: 10.1093/jac/dkaa244
San-Juan R, Martínez-Redondo I, Fernández-Ruiz M, et al. A short course of antibiotic treatment is safe after catheter withdrawal in catheter-related bloodstream infections due to coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis. 2019;38:977–83.
doi: 10.1007/s10096-019-03545-8
Lee Y-M, Moon C, Park K-H. Is short-term antibiotic therapy safe in patients with central venous catheter-related Gram-negative bacteraemia? J Antimicrob Chemother. 2021;76:539–41.
doi: 10.1093/jac/dkaa435
Sandoe JAT, Witherden IR, Au-Yeung H-KC, Kite P, Kerr KG, Wilcox MH. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother. 2002;50:577–82.
doi: 10.1093/jac/dkf182
Marschall J, Piccirillo ML, Fraser VJ, Doherty JA, Warren DK. Catheter removal versus retention in the management of catheter-associated enterococcal bloodstream infections. Can J Infect Dis Med Microbiol. 2013;24:e83–7.
doi: 10.1155/2013/678503
Hebeisen UP, Atkinson A, Marschall J, Buetti N. Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed? Antimicrob Resist Infect Control. 2019;8:21.
doi: 10.1186/s13756-019-0474-x
Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009;49:1187–94.
doi: 10.1086/605694
Surapat B, Montakantikul P, Malathum K, Kiertiburanakul S, Santanirand P, Chindavijak B. Microbial epidemiology and risk factors for relapse in Gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy. BMC Infect Dis. 2020;20:604.
doi: 10.1186/s12879-020-05312-z
Centers for Disease Control and Prevention. National and State Associated Infections Progress Report. Centers for Disease Control and Prevention. 2016. https://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf .
Heilmann C, Ziebuhr W, Becker K. Are coagulase-negative staphylococci virulent? Clin Microbiol Infect. 2019;25:1071–80.
doi: 10.1016/j.cmi.2018.11.012
Timsit J-F, Rupp M, Bouza E, et al. A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill. Intensive Care Med. 2018;44:742–59.
doi: 10.1007/s00134-018-5212-y
Muff S, Hebeisen U, Timsit J-F, Mermel L, Harbarth S, Buetti N. Treatment duration of enterococcal intravascular catheter-related infections. Clin Microbiol Infect. 2020;S1198-743X:30717-5.